Therapy for pulmonary arterial hypertension associated with systemic sclerosis
Authors:
- 1 November 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 21 (6) , 642-648
Abstract
Purpose of review Systemic sclerosis is commonly complicated by pulmonary arterial hypertension (PAH-SSc) and is a leading cause of death in this population. We will review existing challenges and recent advances in the treatment of this disease. Recent findings Traditionally employed outcome measures in pulmonary arterial hypertension research may not be applicable in PAH-SSc. Importantly, new therapies that target abnormal cellular proliferation in the pulmonary vasculature are currently under investigation and may be particularly relevant to PAH-SSc. Summary Pulmonary arterial hypertension complicating systemic sclerosis occurs commonly and portends a poor prognosis. However, recent advances in our understanding of the disease in the context of systemic sclerosis may lead to novel diagnostic and therapeutic strategies that will ultimately improve quality of life and survival in this population.Keywords
This publication has 65 references indexed in Scilit:
- Tadalafil Therapy for Pulmonary Arterial HypertensionCirculation, 2009
- Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseasesAnnals of the Rheumatic Diseases, 2008
- Possible role of imatinib in clinical pulmonary veno-occlusive disease: Fig. 1—European Respiratory Journal, 2008
- Hyponatremia Predicts Right Heart Failure and Poor Survival in Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Identification of candidate genes in scleroderma-related pulmonary arterial hypertensionTranslational Research, 2008
- Selective endothelinA receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue diseaseAnnals of the Rheumatic Diseases, 2007
- Changes in causes of death in systemic sclerosis, 1972–2002Annals of the Rheumatic Diseases, 2007
- Long term imatinib treatment in pulmonary arterial hypertensionThorax, 2006
- A study of the prevalence of systemic sclerosis in northeast EnglandRheumatology, 2004
- Endothelial Dysfunction in Pulmonary HypertensionCirculation, 2004